Remove Compliance Remove Marketing Remove Pharma Companies Remove Regulation
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

Marketing 100
article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can J&J’s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties. Ethical leadership!

article thumbnail

Virtual Reality & Augmented Reality: Innovations in Pharma Advertising

Pharma Marketing Network

Benefits of VR & AR in Pharma Advertising VR and AR offer a unique opportunity for pharma companies to engage with customers in a more immersive and interactive way. For example, by using VR and AR, a pharma company could create an interactive 3D environment that allows customers to explore the product in detail.

article thumbnail

How can the pharma industry navigate issues in the global supply chain to minimise drug shortages?

pharmaphorum

That means maintaining regulatory readiness – because having cGMP compliance problems with the FDA can significantly exacerbate the problem. Until the company is found to be in compliance, there will not be a normal distribution of drug products. You can check out part 1 of this series, on maintaining GMP readiness, here.

article thumbnail

AI-Powered Precision Engagement in Commercial and Medical Functions

Intouch Solutions

Precision engagement is a data-driven approach developed for marketing and sales needs. In the pharma industry, precision engagement can be used to present patients, healthcare professionals (HCPs), and other stakeholders with relevant information and support at the right time. So, what is precision engagement?

article thumbnail

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

pharmaphorum

The move to online international meetings has left pharma companies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.